SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007187
Filing Date
2024-05-08
Accepted
2024-05-08 07:07:39
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20240331x10q.htm   iXBRL 10-Q 1379147
2 EX-31.1 mrns-20240331xex31d1.htm EX-31.1 13387
3 EX-31.2 mrns-20240331xex31d2.htm EX-31.2 13515
4 EX-32.1 mrns-20240331xex32d1.htm EX-32.1 7703
5 GRAPHIC mrns-20240331x10q004.jpg GRAPHIC 14134
6 GRAPHIC mrns-20240331x10q007.jpg GRAPHIC 62681
  Complete submission text file 0001558370-24-007187.txt   6851199

Data Files

Seq Description Document Type Size
7 EX-101.SCH mrns-20240331.xsd EX-101.SCH 58483
8 EX-101.CAL mrns-20240331_cal.xml EX-101.CAL 51493
9 EX-101.DEF mrns-20240331_def.xml EX-101.DEF 176723
10 EX-101.LAB mrns-20240331_lab.xml EX-101.LAB 456046
11 EX-101.PRE mrns-20240331_pre.xml EX-101.PRE 310320
77 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20240331x10q_htm.xml XML 1091176
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 24924216
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)